Direct Impact

Concepts for which Jan A Walewski has direct influence:

chop induction
indolent lymphoma
months chemotherapy
response rates
free survival
maintenance event
efs treated

Prominent publications by Jan A Walewski

KOL-Index: 5 BACKGROUND: Treatment of early-stage Hodgkin's disease is usually tailored in line with prognostic factors that allow for reductions in the amount of chemotherapy and extent of radiotherapy required for a possible cure. METHODS: From 1993 to 1999, we identified 1538 patients (age, 15 to 70 years) who had untreated stage I or II supradiaphragmatic Hodgkin's disease with favorable prognostic ...
Known for
Favorable Prognostic Features | Estimated 5-Year Event-Free Survival | Early-Stage Hodgkins | Subtotal Nodal
KOL-Index: 2 Evaluation of event free survival (EFS) of patients treated with the study chemotherapy induction program: R-CHOP compared to the standard R-CVP regimen and response rates, time to best response, PFS, OS, neutropenic fever rate, infection rate, change in Ig levels, change in lymphocyte subpopulations counts in previously untreated indolent lymphoma patients in need of systemic treatment. ...

© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172